A Novel WNT Pathway Inhibitor, SM04690, for the Treatment of Moderate to Severe Osteoarthritis of the Knee: Results of a 24-Week, Randomized, Controlled, Phase 1 Study

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2017.07.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

OP0166 Radiographic Outcomes From a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Injectable, WNT Pathway Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Week 26 Interim Analysis

2017English

Efficacy and Safety From a Phase 2B Trial of SM04690, a Novel, Intra-Articular, WNT Pathway Inhibitor for the Treatment of Osteoarthritis of the Knee

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Discovery of a Small Molecule Inhibitor of the WNT Pathway (SM04690) as a Potential Disease Modifying Treatment for Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2016English

The Effect of Secukinumab on Moderate-To-Severe Scalp Psoriasis: Results of a 24-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3b Study

Journal of the American Academy of Dermatology
Dermatology
2017English

To: A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease

Neurology
Neurology
2001English

Comparison of Intra-Articular Sham and Vehicle Injection From a Phase 2b Trial of SM04690, a Small-Molecule WNT Inhibitor, for Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of the Knee: A Randomized Controlled Study

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2011English

Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study

Drugs in R and D
Pharmacology
2020English

SM04690, a Potential Disease-Modifying Treatment for Knee Osteoarthritis, Functions Through Inhibition of CLK2 and DYRK1A, Novel Molecular Regulators of WNT Signaling, Chondrogenesis, and Inflammation

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy